It is noteworthy that the Ndel1 CKO mice affords us not only the exciting opportunity to study the postnatal role of the MT cytoskeleton in epileptogenesis, but also it will enable us to further promote the development of novel therapeutic agents for the treatment of epilepsy, as exemplified by our Reelin experiments. This evidence concerns the gene NDEL1 and epilepsy.